BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical Reports Second Quarter 2026 Financial Results

Xtant Medical (XTNT)Xtant MedicalEarnings

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th, at 8:30am ET BELGRADE, Mont., Aug.

Related news

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

IRIXIRIDEX2026-08-18 20:05 EST

Iridex Reports Second Quarter 2026 Financial Results

PAVMPAVmed2026-08-14 12:00 EST

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

PAVMPAVmed2026-08-13 12:00 EST

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

STIMNeuronetics2026-08-11 11:50 EST

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

TCMDTactile Systems Technology, Inc.2026-08-10 20:05 EST

Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

AORTArtivion2026-08-06 20:05 EST

Artivion Reports Second Quarter 2026 Financial Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

View all latest news

Xtant Medical

Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures. Biologics and Implants The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments. Hemostasis Expansion An exclusive U.S. distribution agreement...

Recent company news

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Stock data

Close
0.33 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States